Intronic promoter drives the BORIS-regulated expression of FerT in colon carcinoma cells

Journal of Biological Chemistry

Volumn 287, Issue 9, 2012, Pages 6100-6112

  Makovski, Adar ^a   Yaffe, Etai ^a   Shpungin, Sally ^a   Nir, Uri ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELLS; COLON CARCINOMA CELLS; COLORECTAL TUMORS; DNA METHYLATION; DOWN-REGULATION; EXPRESSION PROFILE; HUMAN CELLS; MAMMALIAN TISSUES; NEW MEMBERS; PROTEIN FAMILY; REGULATORY MECHANISM; SOMATIC TISSUES; SPERMATOGENIC CELLS; TYROSINE KINASE;

AMINO ACIDS; CYTOLOGY; GENES; HISTOLOGY; MAMMALS; RNA; TISSUE; TRANSCRIPTION; TRANSCRIPTION FACTORS;

CELLS;

BROTHER OF THE REGULATOR OF IMPRINTED SITES TRANSCRIPTION FACTOR; CANCER TESTIS ANTIGEN; FERT PROTEIN; PROTEIN KINASE FER; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; COLON CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FER GENE; FERT GENE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INTRON; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL CYCLE; COLONIC NEOPLASMS; DNA METHYLATION; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 84857488002     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.327106     Document Type: Article

References (35)

1. Hao, Q. L., Heisterkamp, N., and Groffen, J. (1989) Isolation and sequence analysis of a novel human tyrosine kinase gene. Mol. Cell Biol. 9, 1587-1593 (Pubitemid 19095198)
2. 2 terminus and is affected by kinase domain integrity and ATP binding. Cell Growth Differ. 10, 113-129
3. Letwin, K., Yee, S. P., and Pawson, T. (1988) Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody. Oncogene 3, 621-627 (Pubitemid 19030371)
4. Pasder, O., Shpungin, S., Salem, Y., Makovsky, A., Vilchick, S., Michaeli, S., Malovani, H., and Nir, U. (2006) Down-regulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene 25, 4194-4206 (Pubitemid 44079453)
5. Allard, P., Zoubeidi, A., Nguyen, L. T., Tessier, S., Tanguay, S., Chevrette, M., Aprikian, A., and Chevalier, S. (2000) Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Mol. Cell Endocrinol. 159, 63-77 (Pubitemid 30067641)
6. Fischman, K., Edman, J. C., Shackleford, G. M., Turner, J. A., Rutter, W. J., and Nir, U. (1990) A murine fer testis-specific transcript (ferT) encodes a truncated Fer protein. Mol. Cell Biol. 10, 146-153
7. Hazan, B., Bern, O., Carmel, M., Lejbkowicz, F., Goldstein, R. S., and Nir, U. (1993) ferT encodes a meiosis-specific nuclear tyrosine kinase. Cell Growth Differ. 4, 443-449
8. Keshet, E., Itin, A., Fischman, K., and Nir, U. (1990) The testis-specific transcript (ferT) of the tyrosine kinase FER is expressed during spermatogenesis in a stage-specific manner. Mol. Cell Biol. 10, 5021-5025
9. Kierszenbaum, A. L., Rivkin, E., and Tres, L. L. (2008) Expression of Fer testis (FerT) tyrosine kinase transcript variants and distribution sites of FerT during the development of the acrosome-acroplaxome-manchette complex in rat spermatids. Dev. Dyn. 237, 3882-3891
10. Priel-Halachmi, S., Ben-Dor, I., Shpungin, S., Tennenbaum, T., Molavani, H., Bachrach, M., Salzberg, S., and Nir, U. (2000) FER kinase activation of Stat3 is determined by the N-terminal sequence. J. Biol. Chem. 275, 28902-28910
11. Scanlan, M. J., Simpson, A. J., and Old, L. J. (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1
12. Baylin, S. B., and Herman, J. G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168-174 (Pubitemid 30169152)
13. Zendman, A. J., Ruiter, D. J., and Van Muijen, G. N. (2003) Cancer/testis-associated genes: identification, expression profile, and putative function. J. Cell Physiol. 194, 272-288 (Pubitemid 36176890)
14. Koslowski, M., Bell, C., Seitz, G., Lehr, H. A., Roemer, K., Müntefering, H., Huber, C., Sahin, U., and Türeci, O. (2004) Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res. 64, 5988-5993 (Pubitemid 39129395)
15. Caballero, O. L., and Chen, Y. T. (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100, 2014-2021
16. Almeida, L. G., Sakabe, N. J., deOliveira, A. R., Silva, M. C., Mundstein, A. S., Cohen, T., Chen, Y. T., Chua, R., Gurung, S., Gnjatic, S., Jungbluth, A. A., Caballero, O. L., Bairoch, A., Kiesler, E., White, S. L., Simpson, A. J., Old, L. J., Camargo, A. A., and Vasconcelos, A. T. (2009) CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res. 37, D816-819
17. Scudellari, M. (2011) A ballsy search for cancer targets. Nature Med. 17, 916-918
18. Woloszynska-Read, A., James, S. R., Link, P. A., Yu, J., Odunsi, K., and Karpf, A. R. (2007) DNA methylation-dependent regulation of BORIS/ CTCFL expression in ovarian cancer. Cancer Immun. 7, 21
19. Hikri, E., Shpungin, S., and Nir, U. (2009) Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity. Cell Signal 21, 588-596
20. Nguyen, P., Cui, H., Bisht, K. S., Sun, L., Patel, K., Lee, R. S., Kugoh, H., Oshimura, M., Feinberg, A. P., and Gius, D. (2008) CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. Cancer Res. 68, 5546-5551
21. Carmel, M., Shpungin, S., and Nir, U. (2000) Role of positive and negative regulation in modulation of the Fer promoter activity. Gene. 241, 87-99
22. van Engeland, M., Ramaekers, F. C., Schutte, B., and Reutelingsperger, C. P. (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24, 131-139
23. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985 (Pubitemid 23267698)
24. Klenova, E. M., Morse, H. C., 3rd, Ohlsson, R., and Lobanenkov, V. V. (2002) The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol 12, 399-414
25. D'Arcy, V., Pore, N., Docquier, F., Abdullaev, Z. K., Chernukhin, I., Kita, G. X., Rai, S., Smart, M., Farrar, D., Pack, S., Lobanenkov, V., and Klenova, E. (2008) BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. Br. J. Cancer 98, 571-579 (Pubitemid 351214517)
26. Hong, J. A., Kang, Y., Abdullaev, Z., Flanagan, P. T., Pack, S. D., Fischette, M. R., Adnani, M. T., Loukinov, D. I., Vatolin, S., Risinger, J. I., Custer, M., Chen, G. A., Zhao, M., Nguyen, D. M., Barrett, J. C., Lobanenkov, V. V., and Schrump, D. S. (2005) Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res. 65, 7763-7774 (Pubitemid 41297251)
27. Smith, I. M., Glazer, C. A., Mithani, S. K., Ochs, M. F., Sun, W., Bhan, S., Vostrov, A., Abdullaev, Z., Lobanenkov, V., Gray, A., Liu, C., Chang, S. S., Ostrow, K. L., Westra, W. H., Begum, S., Dhara, M., and Califano, J. (2009) Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS ONE 4, e4961
28. Vatolin, S., Abdullaev, Z., Pack, S. D., Flanagan, P. T., Custer, M., Loukinov, D. I., Pugacheva, E., Hong, J. A., Morse, H., 3rd, Schrump, D. S., Risinger, J. I., Barrett, J. C., and Lobanenkov, V. V. (2005) Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res. 65, 7751-7762 (Pubitemid 41297250)
29. Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., and Ehrlich, M. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11, 6883-6894
30. Goelz, S. E., Vogelstein, B., Hamilton, S. R., and Feinberg, A. P. (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187-190 (Pubitemid 15117274)
31. Feinberg, A. P., Gehrke, C. W., Kuo, K. C., and Ehrlich, M. (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159-1161 (Pubitemid 18075525)
32. Renaud, S., Pugacheva, E. M., Delgado, M. D., Braunschweig, R., Abdullaev, Z., Loukinov, D., Benhattar, J., and Lobanenkov, V. (2007) Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Nucleic Acids Res. 35, 7372-7388
33. Boon, T., and Old, L. J. (1997) Cancer tumor antigens. Current Opin. Immunol. 9, 681-683
34. Jones, P. A. (1985) Altering gene expression with 5-azacytidine. Cell 40, 485-486
35. Bhan, S., Negi, S. S., Shao, C., Glazer, C. A., Chuang, A., Gaykalova, D. A., Sun, W., Sidransky, D., Ha, P. K., and Califano, J. A. (2011) BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer. Clin. Cancer Res. 17, 4267-4276